UMediC Group Berhad

KLSE:UMC Stock Report

Market Cap: RM 231.8m

UMediC Group Berhad Future Growth

Future criteria checks 5/6

UMediC Group Berhad is forecast to grow earnings and revenue by 22.2% and 20.7% per annum respectively. EPS is expected to grow by 22.5% per annum. Return on equity is forecast to be 16.3% in 3 years.

Key information

22.2%

Earnings growth rate

22.5%

EPS growth rate

Healthcare earnings growth2.5%
Revenue growth rate20.7%
Future return on equity16.3%
Analyst coverage

Low

Last updated05 Dec 2024

Recent future growth updates

Recent updates

UMediC Group Berhad's (KLSE:UMC) Returns On Capital Not Reflecting Well On The Business

Nov 11
UMediC Group Berhad's (KLSE:UMC) Returns On Capital Not Reflecting Well On The Business

UMediC Group Berhad (KLSE:UMC) Hasn't Managed To Accelerate Its Returns

Aug 05
UMediC Group Berhad (KLSE:UMC) Hasn't Managed To Accelerate Its Returns

We Think You Should Be Aware Of Some Concerning Factors In UMediC Group Berhad's (KLSE:UMC) Earnings

Jun 17
We Think You Should Be Aware Of Some Concerning Factors In UMediC Group Berhad's (KLSE:UMC) Earnings

UMediC Group Berhad's (KLSE:UMC) Earnings Are Of Questionable Quality

Dec 18
UMediC Group Berhad's (KLSE:UMC) Earnings Are Of Questionable Quality

Revenue Downgrade: Here's What Analysts Forecast For UMediC Group Berhad (KLSE:UMC)

Dec 12
Revenue Downgrade: Here's What Analysts Forecast For UMediC Group Berhad (KLSE:UMC)

Some Investors May Be Worried About UMediC Group Berhad's (KLSE:UMC) Returns On Capital

Aug 11
Some Investors May Be Worried About UMediC Group Berhad's (KLSE:UMC) Returns On Capital

Robust Earnings May Not Tell The Whole Story For UMediC Group Berhad (KLSE:UMC)

Mar 13
Robust Earnings May Not Tell The Whole Story For UMediC Group Berhad (KLSE:UMC)

Is There An Opportunity With UMediC Group Berhad's (KLSE:UMC) 21% Undervaluation?

Nov 25
Is There An Opportunity With UMediC Group Berhad's (KLSE:UMC) 21% Undervaluation?

Earnings and Revenue Growth Forecasts

KLSE:UMC - Analysts future estimates and past financials data (MYR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
7/31/2027941712163
7/31/20268515263
7/31/202566113103
10/31/202453906N/A
7/31/2024559-24N/A
4/30/2024529-31N/A
1/31/20245010-22N/A
10/31/20234910-42N/A
7/31/20234510-42N/A
4/30/2023418-30N/A
1/31/2023387-21N/A
10/31/202244624N/A
7/31/202251678N/A
7/31/2021345-64N/A
7/31/2020242-5-4N/A
7/31/201916167N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: UMC's forecast earnings growth (22.2% per year) is above the savings rate (3.6%).

Earnings vs Market: UMC's earnings (22.2% per year) are forecast to grow faster than the MY market (10.2% per year).

High Growth Earnings: UMC's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: UMC's revenue (20.7% per year) is forecast to grow faster than the MY market (6.3% per year).

High Growth Revenue: UMC's revenue (20.7% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: UMC's Return on Equity is forecast to be low in 3 years time (16.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 21:20
End of Day Share Price 2024/12/26 00:00
Earnings2024/10/31
Annual Earnings2024/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

UMediC Group Berhad is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ken-Wern LimAffin Hwang Investment Bank
Siu Li ChuaHong Leong Investment Bank Berhad
Chee SiangHong Leong Investment Bank Berhad